Patents by Inventor Vasily Artemov

Vasily Artemov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indole compound as inhibitor of necrosis
    Patent number: 10927097
    Abstract: The present application relates to an indole compound represented by formula (1): a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: February 23, 2021
    Assignee: LG CHEM, LTD.
    Inventors: Heui Sul Park, Sun Young Koo, Hyoung Jin Kim, Sung Bae Lee, Hyo Shin Kwak, Vasily Artemov, Soon Ha Kim
  • Thioaryl derivatives as GPR120 agonists
    Patent number: 9447044
    Abstract: The present invention relates to thioaryl derivatives of Formula 1 as defined in the specification, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The thioaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in macrophages, pancreas cells, etc. due to anti-inflammatory action, and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, inflammation, obesity, non-alcoholic fatty liver, steatohepatitis or osteoporosis.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: September 20, 2016
    Assignee: LG LIFE SCIENCES LTD.
    Inventors: Young Kwan Kim, Myoung Yeol Kim, Sang Yun Park, Ok Ku Park, Vasily Artemov, Sang Dae Lee, Hyun Woo Joo, Eun Sil Choi
  • INDOLE COMPOUND AS INHIBITOR OF NECROSIS
    Publication number: 20160200709
    Abstract: The present invention relates to an indole compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.
    Type: Application
    Filed: August 21, 2014
    Publication date: July 14, 2016
    Applicant: LG LIFE SCIENCES LTD.
    Inventors: Heui Sul PARK, Sun Young KOO, Hyoung Jin KIM, Sung Bae LEE, Hyo Shin KWAK, Vasily ARTEMOV, Soon Ha KIM
  • THIOARYL DERIVATIVES AS GPR120 AGONISTS
    Publication number: 20150291527
    Abstract: The present invention relates to thioaryl derivatives of Formula 1 as defined in the specification, a method for preparing the same, a pharmaceutical composition comprising the same and use thereof. The thioaryl derivatives of Formula 1 according to the present invention promote GLP-1 formation in the gastrointestinal tract and improve insulin resistance in macrophages, pancreas cells, etc. due to anti-inflammatory action, and can accordingly be effectively used for preventing or treating diabetes, complications of diabetes, inflammation, obesity, non-alcoholic fatty liver, steatohepatitis or osteoporosis.
    Type: Application
    Filed: November 5, 2013
    Publication date: October 15, 2015
    Applicant: LG LIFE SCIENCES LTD.
    Inventors: Young Kwan Kim, Myoung Yeol Kim, Sang Yun Park, Ok Ku Park, Vasily Artemov, Sang Dae Lee, Hyun Woo Joo, Eun Sil Choi
  • Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
    Patent number: 8729273
    Abstract: The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: May 20, 2014
    Assignee: LG Life Sciences Ltd.
    Inventors: Jeong Uk Song, Geun Tae Kim, Sung Pil Choi, Cheol Kyu Jung, Deok Seong Park, Eun Sil Choi, Tae Hun Kim, Hyun Jung Park, Wan Su Park, Heui Sul Park, Ki Chul Koo, Vasily Artemov
  • NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
    Publication number: 20120184582
    Abstract: The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.
    Type: Application
    Filed: October 4, 2010
    Publication date: July 19, 2012
    Inventors: Jeong Uk Song, Geun Tae Kim, Sung Pil Choi, Cheol Kyu Jung, Deok Seong Park, Eun Sil Choi, Tae Hun Kim, Hyun Jung Park, Wan Su Park, Heui Sul Park, Ki Chul Koo, Vasily Artemov